<DOC>
	<DOC>NCT01791920</DOC>
	<brief_summary>To compare the safety and efficacy of Botulax速 with Botox速 in the improvement of moderate to severe glabellar lines.</brief_summary>
	<brief_title>To Evaluate the Safety and Efficacy of Botulax速 Are Not Inferior to Those of Botox速 in the Treatment of Glabellar Lines</brief_title>
	<detailed_description />
	<mesh_term>Botulinum Toxins, Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Men and women aged between 18 and 65 Patients attaining grade 2 or 3 in the investigator's rating of glabellar lines severity at maximum frown Patients who voluntarily sign the informed consent Patients who can comply with the study procedures and visit schedule Subjects who had facial plastic surgery (tissue augmentation, brow lift, and dermal resurfacing)treatment within 6 months. Those who had peeling or laser therapy Subjects with skin disorders, scar or infection around glabellar region Subjects who are taking Aspirin, NSAIDS or anticoagulant Subjects with facial palsy or eyelid ptosis Subjects who diagnosed as neuromuscular junction disorder (e.g., myasthenia gravis, LambertEaton Syndrome) Subjects with history of drug intoxication, alcohol abuse and/or depressive disorder Subjects with severe internal diseases (cardiovascular, respiratory, renal disease, liver disorder) Subjects who have previously been treated with botulinum toxin within 3 months (Botulinum toxin type A: 3months, type B: 4 months) Subject who have administered following drugs within the previous 4 months: Spectinomycin Hydrochloride, Aminoglycoside antibiotics, polypeptide antibiotics, tetracycline antibiotics, lincomycin antibiotics, muscle relaxants, anticholinergic agents, benzodiazepine and similar drugs, benzamide drugs, Tubocurarinetype muscle relaxants Subjects who have possibility to take the drugs listed above Subjects who have a plan to receive facial cosmetic procedures including dermal filler, chemical peeling and dermabrasion during study period Subjects who have glabellar lines that are unable to be improved with any physical method Subjects who have history of hypersensitivity to Botulinum toxin and other agents Subjects who are pregnant or breastfeeding Subjects who have a plan to be pregnant in 3months, or who are not doing contraceptive Subjects who participated in other studies within 30 days or were not passed over 5 times of half life for investigational product Subjects who are having trouble with acute disease Subjects who have taken any treatment that can affect to glabellar lines and/or any lines around forehead within the previous 6 months Subjects who are unable to communicate or follow the instructions Subjects who are not eligible for this study based on investigator's judgement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>